MetabolicTirzepatide
Dual GIP/GLP-1 receptor agonist for advanced metabolic research.
- Dual incretin pathway activation
- Studied for glycemic regulation
Metabolic
Semaglutide
GLP-1 receptor agonist analog studied in metabolic and glucose regulation research.
Purity
≥ 99% (HPLC)
Form
Lyophilized powder · 5 mg vial
Overview
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) analog used widely in research focused on metabolic regulation, appetite, and insulin response.
Key Benefits
- Studied for glucose homeostasis
- Appetite regulation research
- Investigated weight management pathways
Research Applications
Metabolic studiesDiabetic model researchCardiometabolic research
Educational Note
Semaglutide binds to GLP-1 receptors, prolonging incretin activity and influencing gastric emptying.
Related Products
MetabolicMetabolicMOTS-c
Mitochondrial-derived peptide studied in metabolic homeostasis research.
- Mitochondrial signaling research
- Insulin sensitivity studies
MetabolicAOD-9604
Modified fragment of hGH studied for lipolytic activity.
- Lipolysis research
- No IGF-1 elevation